After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
As China becomes a major source of global clinical trial evidence, the retraction of a high-profile China-led lung cancer study is raising questions about whether journals, regulators and drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results